[Treatment with beta-interferon should be started already after the first attack of MS].
Söderström
M
M
Ogonkliniken och MS Centrum, Huddinge Universitetssjukhus.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D018849:Controlled Clinical Trials as Topic; D003657:Decision Making; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D009902:Optic Neuritis / Q000175:diagnosis; D010358:Patient Participation; D017410:Practice Guidelines as Topic; D011379:Prognosis; D014342:Truth Disclosure
D000276:Adjuvants, Immunologic; D016899:Interferon-beta